Intranasal insulin: Phase II started

NSTK began a dose-ranging Phase II trial in 20 patients to compare its insulin nasal spray compared to NovoLog insulin aspart from Novo Nordisk A/S (CSE:NVO; NVO, Bagsvaerd, Denmark). ...